OcyonBio announces manufacturing to develop biosimilar drug product facilities for Biosimilar Solutions, Inc. OcyonBio is creating an advanced therapy contract..

SSEQENS announced a multi million dollar investment in its research & development laboratory located in Devens, Mass. The improvements will ensure that the new facility will operate at the highest...

BioMed X, announces the start of its new research project Regulatory T Cell Dysfunction in Autoimmunity and Inflammaging in collaboration with Merck KGaA, Darmstadt, Germany. The main objective of the research group ...